Camargo Pharmaceutical Services (Formulation rights for solifenacin) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Camargo Pharmaceutical Services (Formulation rights for solifenacin) General Information

Description

A right to chemical formulation for overactive bladder. The formula leads to a drug for the treatment of uncontrollable and sudden urge to urinate in elderly men and women and urinary incontinence.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 9825 Kenwood Road
  • Suite 203
  • Cincinnati, OH 45242
  • United States
Primary Industry
Buildings and Property
Acquirer
Corporate Office
  • 9825 Kenwood Road
  • Suite 203
  • Cincinnati, OH 45242
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Camargo Pharmaceutical Services (Formulation rights for solifenacin) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Camargo Pharmaceutical Services (Formulation rights for solifenacin)‘s full profile, request access.

Request a free trial

Camargo Pharmaceutical Services (Formulation rights for solifenacin) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Camargo Pharmaceutical Services (Formulation rights for solifenacin)‘s full profile, request access.

Request a free trial

Camargo Pharmaceutical Services (Formulation rights for solifenacin) FAQs

  • Where is Camargo Pharmaceutical Services (Formulation rights for solifenacin) headquartered?

    Camargo Pharmaceutical Services (Formulation rights for solifenacin) is headquartered in Cincinnati, OH.

  • What industry is Camargo Pharmaceutical Services (Formulation rights for solifenacin) in?

    Camargo Pharmaceutical Services (Formulation rights for solifenacin)’s primary industry is Buildings and Property.

  • Is Camargo Pharmaceutical Services (Formulation rights for solifenacin) a private or public company?

    Camargo Pharmaceutical Services (Formulation rights for solifenacin) is a Private company.

  • What is Camargo Pharmaceutical Services (Formulation rights for solifenacin)’s current revenue?

    The current revenue for Camargo Pharmaceutical Services (Formulation rights for solifenacin) is .

  • Who are Camargo Pharmaceutical Services (Formulation rights for solifenacin)’s investors?

    Camargo Pharmaceutical Services has invested in Camargo Pharmaceutical Services (Formulation rights for solifenacin).

  • When was Camargo Pharmaceutical Services (Formulation rights for solifenacin) acquired?

    Camargo Pharmaceutical Services (Formulation rights for solifenacin) was acquired on 11-Dec-2017.

  • Who acquired Camargo Pharmaceutical Services (Formulation rights for solifenacin)?

    Camargo Pharmaceutical Services (Formulation rights for solifenacin) was acquired by Veru.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process